COVID-19 pharmacy student perceptions: pharmacists' impact during the COVID-19 pandemic
1Department of Pharmacy, Temple University, Philadelphia, PA 19140, USA
2Centre for Research and Development, Region Gävleborg/Uppsala University, 80320 Gävle, Sweden
3Department of Medicine, Cardiology Research Unit, Karolinska Institutet, 11153 Stockholm, Sweden
4Clinical Research, NEMA Research Inc., Naples, FL 34108, USA
Submitted: 30 April 2021 Accepted: 09 July 2021
Online publish date: 17 September 2021
Pharmacists around the world are playing an active role in educating the public about COVID-19. First-year pharmacy students taking a healthcare course at Temple University in Philadelphia were asked to write papers based on the nature of a pharmacist’s contributions during the pandemic. 90% of the essays outlined the importance of community pharmacists, as they are the most accessible healthcare professional, providing immediate social interaction and drug expertise. They help minimize the need for hospital visits, limiting their time in public, therefore reducing their risk of becoming infected. For the pharmacies that have a drive-thru window, over-the-counter medications and other necessities can be sold to decrease the likelihood of transmission. Many students also proposed the opportunity for more leniency in prescribing power. Unless pharmacists are within a collaborative practice agreement, they cannot prescribe even maintenance medication. Due to the pandemic, it has become increasingly hard to reach the doctor or see them in person, as most offices have switched to telehealth. Clinical pharmacists operating out of hospitals have the opportunity to oversee proposed treatment options or experimental drugs, such as remdesivir. Retail pharmacies are emerging as key resources in this pandemic, and it is important that students see this as a vibrant and important form of pharmacy practice.
COVID-19; Pandemic; Pharmacy; Pharmacists; Students; Industry; Community; Hospital
Bryan Zhang,Justina Refela,Frank Breve,Peter Magnusson,Joseph Pergolizzi. COVID-19 pharmacy student perceptions: pharmacists' impact during the COVID-19 pandemic. Signa Vitae. 2021.doi:10.22514/sv.2021.208.
 Hoti K, Jakupi A, Hetemi D, Raka D, Hughes J, Desselle S. Provision of community pharmacy services during COVID-19 pandemic: a cross sectional study of community pharmacists’ experiences with preventative measures and sources of information. International Journal of Clinical Pharmacy. 2020; 42: 1197–1206.
 Merks P, Jakubowska M, Drelich E, Świeczkowski D, Bogusz J, Bilmin K, et al. The legal extension of the role of pharmacists in light of the COVID-19 global pandemic. Research in Social and Administrative Pharmacy. 2020; 17: 1807–1812.
 Erku DA, Belachew SA, Abrha S, Sinnollareddy M, Thomas J, Steadman KJ, et al. When fear and misinformation go viral: Pharmacists’ role in deterring medication misinformation during the ‘infodemic’ surrounding COVID-19. Research in Social and Administrative Pharmacy. 2021; 17: 1954–1963.
 Strand MA, Bratberg J, Eukel H, Hardy M, Williams C. Community Pharmacists’ Contributions to Disease Management During the COVID-19 Pandemic. Preventing Chronic Disease. 2020; 17: E69.
 Di Girolamo N, Meursinge Reynders R. Characteristics of scientific articles on COVID-19 published during the initial 3 months of the pandemic. Scientometrics. 2020; 125: 795–812.
 Elbeddini A, Prabaharan T, Almasalkhi S, Tran C. Pharmacists and COVID-19. Journal of Pharmaceutical Policy and Practice. 2020; 13: 36.
 Hayden JC, Parkin R. The challenges of COVID-19 for community phar-macists and opportunities for the future. Irish Journal of Psychological Medicine. 2020; 37: 198–203.
 Karasneh R, Al-Azzam S, Muflih S, Soudah O, Hawamdeh S, Khader Y. Media’s effect on shaping knowledge, awareness risk perceptions and communication practices of pandemic COVID-19 among pharmacists. Research in Social and Administrative Pharmacy. 2021; 17: 1897–1902.
 Johnston K, O’Reilly CL, Cooper G, Mitchell I. The burden of COVID-19 on pharmacists. Journal of the American Pharmacists Association. 2021; 61: e61–e64.
 Zheng S, Yang L, Zhou P, Li H, Liu F, Zhao R. Recommendations and guidance for providing pharmaceutical care services during COVID-19 pandemic: a China perspective. Research in Social and Administrative Pharmacy. 2021; 17: 1819–1824.
 Li H, Zheng S, Liu F, Liu W, Zhao R. Fighting against COVID-19: Innovative strategies for clinical pharmacists. Research in Social and Administrative Pharmacy. 2021; 17: 1813–1818.
 Song Z, Hu Y, Zheng S, Yang L, Zhao R. Hospital pharmacists’ pharmaceutical care for hospitalized patients with COVID-19: Recom-mendations and guidance from clinical experience. Research in Social and Administrative Pharmacy. 2021; 17: 2027–2031.
 Mallhi TH, Liaqat A, Abid A, Khan YH, Alotaibi NH, Alzarea AI, et al. Multilevel Engagements of Pharmacists During the COVID-19 Pandemic: The Way Forward. Frontiers in Public Health. 2020; 8: 561924.
 Baye AM, Ababu A, Bayisa R, Abdella M, Diriba E, Wale M, et al. Perspectives of compounding pharmacists on alcohol-based hand sanitizer production and utilization for COVID-19 prevention in Addis Ababa, Ethiopia: A descriptive phenomenology study. PLoS ONE. 2021; 16: e0250020.
 Bragazzi NL, Mansour M, Bonsignore A, Ciliberti R. The Role of Hospital and Community Pharmacists in the Management of COVID-19: Towards an Expanded Definition of the Roles, Responsibilities, and Duties of the Pharmacist. Pharmacy. 2020; 8: 140.
Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,200 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.
Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.
Chemical Abstracts Service Source Index The CAS Source Index (CASSI) Search Tool is an online resource that can quickly identify or confirm journal titles and abbreviations for publications indexed by CAS since 1907, including serial and non-serial scientific and technical publications.
IndexCopernicus The Index Copernicus International (ICI) Journals database’s is an international indexation database of scientific journals. It covered international scientific journals which divided into general information, contents of individual issues, detailed bibliography (references) sections for every publication, as well as full texts of publications in the form of attached files (optional). For now, there are more than 58,000 scientific journals registered at ICI.
Geneva Foundation for Medical Education and Research The Geneva Foundation for Medical Education and Research (GFMER) is a non-profit organization established in 2002 and it works in close collaboration with the World Health Organization (WHO). The overall objectives of the Foundation are to promote and develop health education and research programs.
Scopus: CiteScore 0.5(2019) Scopus is Elsevier's abstract and citation database launched in 2004. Scopus covers nearly 36,377 titles (22,794 active titles and 13,583 Inactive titles) from approximately 11,678 publishers, of which 34,346 are peer-reviewed journals in top-level subject fields: life sciences, social sciences, physical sciences and health sciences.
Embase Embase (often styled EMBASE for Excerpta Medica dataBASE), produced by Elsevier, is a biomedical and pharmacological database of published literature designed to support information managers and pharmacovigilance in complying with the regulatory requirements of a licensed drug.